MK2 is a therapeutic target for high-risk multiple myeloma.

ABSTRACT:

SUBMITTER: Gu C 

PROVIDER: S-EPMC8168486 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature